Home » CLL / SLL Patient Education Toolkit » Test Before Treat One-pager
Test Before Treat™ One-pager
In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.
The PDF document below is a one-page summary of what you need to know about the three most important tests that need to be performed to guide your CLL or SLL treatment selection.
Please read it and print it out to share with your healthcare provider, if need be, or with other patients who might also benefit from this information.
ADDITIONAL READING
Dr. Pagel is a CLL specialist out of Swedish Hospital, Seattle. WA whom I interviewed at ASH 2017 about a project that is close to my heart, quality improvement. Our motto is smart patients get smart care. Dr. Pagel is writing the corollary: Smart doctors give smart care. What Dr.
Dr. Constantine Tam of Peter MacCallum Cancer Center, Melbourne, Australia has contributed important research for chronic lymphocytic leukemia patients while working at PeterMac in Australia and MD Anderson in Texas. I interviewed Dr. Tam at ASH 2017 in Atlanta, Georgia about his research into an important prognostic and predictive
By Manali Kamdar, MD The presentation and course of CLL is strikingly varied in patients, with some individuals presenting with a biologically indolent course whereas others present with an aggressive course. Hence, it is imperative to get information about individual patient prognosis in order to define a therapeutic strategy
In this short but pithy news interview, Dr. Jeff Jones from Ohio State explains why it so very important to know the details of your cancer before starting on any treatment. It could be a matter of life or death. Please enjoy this brief and helpful interview: You can
By Michael Choi, MD It is a tremendous understatement to say that one should not take a “one-size fits all” approach to the treatment of patients with chronic lymphocytic leukemia. There is tremendous variability in all aspects of the disease. While some patients remain without symptoms for several years,